Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer-Reference-Cited by-同舟云学术

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer

Published:2022-08 Issue:4 Volume:7 Page:100518
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Kanesvaran R.,Castro E.,Wong A.,Fizazi K.,Chua M.L.K.,Zhu Y.,Malhotra H.,Miura Y.,Lee J.L.,Chong F.L.T.,Pu Y.-S.,Yen C.-C.,Saad M.,Lee H.J.,Kitamura H.,Prabhash K.,Zou Q.,Curigliano G.,Poon E.,Choo S.P.,Peters S.,Lim E.,Yoshino T.,Pentheroudakis G.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference136 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Epidemiology and genomics of prostate cancer in Asian men;Zhu;Nat Rev Urol,2021

3. Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia;Kitagawa;Asian J Androl,2015

4. Increasing incidence of prostate cancer in Taiwan: a study of related factors using a nationwide health and welfare database;Lin;Medicine (Baltimore),2020

5. Genetic structure, divergence and admixture of Han Chinese, Japanese and Korean populations;Wang;Hereditas,2018

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 177Lu-PSMA-617 for metastatic prostate cancer in India;The Lancet Regional Health - Southeast Asia;2024-11

2. The combination of immune checkpoint inhibitors and antibody-drug conjugates in the treatment of urogenital tumors: a review insights from phase 2 and 3 studies;Cell Death & Disease;2024-06-19

3. International Variations in Adherence to Quality Metrics for Locoregional Prostate Cancer;European Urology Oncology;2024-06

4. Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapy;BMC Cancer;2024-05-25

5. Development and validation of a deep learning-based microsatellite instability predictor from prostate cancer whole-slide images;npj Precision Oncology;2024-04-09